These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 15339683)
1. Anti-tissue factor pathway inhibitor activity in subjects with antiphospholipid syndrome is associated with increased thrombin generation. Adams M; Breckler L; Stevens P; Thom J; Baker R; Oostryck R Haematologica; 2004 Aug; 89(8):985-90. PubMed ID: 15339683 [TBL] [Abstract][Full Text] [Related]
2. The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generation. Lean SY; Ellery P; Ivey L; Thom J; Oostryck R; Leahy M; Baker R; Adams M Haematologica; 2006 Oct; 91(10):1360-6. PubMed ID: 17018385 [TBL] [Abstract][Full Text] [Related]
3. Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants. Liestøl S; Sandset PM; Jacobsen EM; Mowinckel MC; Wisløff F Br J Haematol; 2007 Jan; 136(1):131-7. PubMed ID: 17092306 [TBL] [Abstract][Full Text] [Related]
4. Antibodies to beta2-glycoprotein I associated with antiphospholipid syndrome suppress the inhibitory activity of tissue factor pathway inhibitor. Salemink I; Blezer R; Willems GM; Galli M; Bevers E; Lindhout T Thromb Haemost; 2000 Oct; 84(4):653-6. PubMed ID: 11057865 [TBL] [Abstract][Full Text] [Related]
5. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus. Adams MJ; Palatinus AA; Harvey AM; Khalafallah AA Lupus; 2011 Dec; 20(14):1474-83. PubMed ID: 21993387 [TBL] [Abstract][Full Text] [Related]
6. Plasma free tissue factor pathway inhibitor (TFPI) levels and TF-induced thrombin generation ex vivo in men with low testosterone levels. Agledahl I; Brodin E; Svartberg J; Hansen JB Thromb Haemost; 2009 Mar; 101(3):471-7. PubMed ID: 19277407 [TBL] [Abstract][Full Text] [Related]
7. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease. Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809 [TBL] [Abstract][Full Text] [Related]
8. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Amengual O; Atsumi T; Khamashta MA; Hughes GR Thromb Haemost; 1998 Feb; 79(2):276-81. PubMed ID: 9493575 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden. Lincz LF; Adams MJ; Scorgie FE; Thom J; Baker RI; Seldon M Blood Coagul Fibrinolysis; 2007 Sep; 18(6):559-64. PubMed ID: 17762532 [TBL] [Abstract][Full Text] [Related]
12. Impact of long-term testosterone treatment on plasma levels of free TFPI and TF-induced thrombin generation ex vivo in elderly men with low testosterone levels. Agledahl I; Brodin E; Svartberg J; Hansen JB Thromb Haemost; 2009 Nov; 102(5):945-50. PubMed ID: 19888533 [TBL] [Abstract][Full Text] [Related]
13. The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation. Sakai Y; Atsumi T; Ieko M; Amengual O; Furukawa S; Furusaki A; Bohgaki M; Kataoka H; Horita T; Yasuda S; Koike T Arthritis Rheum; 2009 Aug; 60(8):2457-67. PubMed ID: 19644870 [TBL] [Abstract][Full Text] [Related]
14. Dilazep and dipyridamole inhibit tissue factor expression on monocytes induced by IgG from patients with antiphospholipid syndrome. Zhou H Acta Pharmacol Sin; 2004 Oct; 25(10):1366-71. PubMed ID: 15456541 [TBL] [Abstract][Full Text] [Related]
15. Regulation of thrombin generation by TFPI in plasma without and with heparin. Brodin E; Appelbom H; Osterud B; Hilden I; Petersen LC; Hansen JB Transl Res; 2009 Mar; 153(3):124-31. PubMed ID: 19218095 [TBL] [Abstract][Full Text] [Related]
16. Increased tissue factor pathway inhibitor (TFPI) and coagulation in patients with insulin-dependent diabetes mellitus. Leurs PB; van Oerle R; Wolffenbuttel BH; Hamulyak K Thromb Haemost; 1997 Mar; 77(3):472-6. PubMed ID: 9065996 [TBL] [Abstract][Full Text] [Related]
17. Identification of thrombin antibodies in patients with antiphospholipid syndrome. Miesbach W; Matthias T; Scharrer I Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540 [TBL] [Abstract][Full Text] [Related]
18. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor. Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842 [TBL] [Abstract][Full Text] [Related]
19. Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons. Lupu C; Kruithof EK; Kakkar VV; Lupu F Thromb Haemost; 1999 Dec; 82(6):1652-8. PubMed ID: 10613651 [TBL] [Abstract][Full Text] [Related]
20. Anticoagulant activity in non-immunoglobulin fraction from plasma of patients with antiphospholipid syndrome. Sugimura M; Su F; Kanayama N; Kobayashi H; Kobayashi T; Terao T Semin Thromb Hemost; 1998; 24(5):473-7. PubMed ID: 9834016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]